Vicks nasal spray recalled in U.S., UK and Germany
By JENNIFER WALKER-JOURNEY

Date: November 23, 2009 12:00 AM

Three lots of Vicks Sinex nasal spray is being recalled in the United States, Germany and the United Kingdom after analysis found the bacteria B. cepacia in a small amount of the product made at a manufacturing plant at Gross Gerau, Germany. The bacteria could cause serious infections for individuals with compromised immune systems or those with chronic lung conditions such as cystic fibrosis.

The manufacturer of the over-the-counter products, The Proctor & Gamble Company (P&G), has received no reports of illness to date. The company states that B cepacia poses only minimal risk to healthy individuals.

The recall includes the following P&G products with the following lot numbers:

  • United States, lot number 9239028831 of Vicks Sinex Vapospray 12-Hour Decongestant Ultra Fine Mist, 15 ml, Nasal Spray
  • United Kingdom, lot number 9224028832 of Vicks Sinex Micromist Aqueous Nasal Spray Solution, 15 ml
  • Germany, lot number 922402883 of Wick Sinex Schnupfenspray Dosiersystem, 15 ml

P&G is removing the recalled products from store shelves and has informed regulatory authorities in the affected countries. Anyone who has these specific lots of this product can call P&G for a replacement coupon or refund at the following numbers:

  • From the United States, please call:  1-877-876-7881 (Hours of operation:  Monday - Friday, 9AM - 6PM US ET, Saturday - Sunday, 9AM - 4PM US ET)
  • From the United Kingdom, please call:  0800-5555-15 (Hours of operation:  19 November, 4PM - 9PM local time and will continue Monday - Friday, 8AM - 6PM local time, Saturday - Sunday, 9AM - 5PM local time)
  • From Germany, please call:  0800-111-6131 (Hours of operation:  19 November, 4PM - 9PM local time and will continue Monday - Friday, 8AM - 6PM local time, Saturday - Sunday, 9AM - 5PM local time)

Any adverse events following use of this or any other product should be reported to the Food and Drug Administration (FDA) MedWatch Program at www.fda.gov/medwatch.

 

Related News